Novartis completes Sandoz spin-off
As a newly independent company, Sandoz will concentrate on developing…
As a newly independent company, Sandoz will concentrate on developing generic and biosimilar medicines, while its former parent company Novartis plans to drive its business forward with a strategic focus on innovative medicines.